EXACT Therapeutics AS (OSL:EXTX)
2.380
0.00 (0.00%)
At close: Jan 12, 2026
EXACT Therapeutics AS Market Cap
EXACT Therapeutics AS has a market cap or net worth of 150.57 million as of January 13, 2026. Its market cap has decreased by -2.95% in one year.
Market Cap
150.57M
Enterprise Value
92.41M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.38
Market Cap Chart
Since July 14, 2020, EXACT Therapeutics AS's market cap has decreased from 953.69M to 150.57M, a decrease of -84.21%. That is a compound annual growth rate of -28.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 13, 2026 | 150.57M | 72.46% |
| Dec 30, 2025 | 87.30M | -63.30% |
| Dec 30, 2024 | 237.87M | -38.21% |
| Dec 29, 2023 | 384.97M | 6.95% |
| Dec 30, 2022 | 359.97M | -31.02% |
| Dec 30, 2021 | 521.86M | -40.97% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 14, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.55B |
| Nordhealth AS | 2.77B |
| Photocure ASA | 2.06B |
| Thor Medical ASA | 1.81B |
| ArcticZymes Technologies ASA | 1.18B |
| Omda AS | 963.86M |
| Vistin Pharma ASA | 922.37M |
| Gentian Diagnostics ASA | 885.24M |